• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RMRP、RMST、FTX和IPW:甲状腺髓样癌中新型潜在长链非编码RNA

RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer.

作者信息

Luzón-Toro Berta, Villalba-Benito Leticia, Fernández Raquel María, Torroglosa Ana, Antiñolo Guillermo, Borrego Salud

机构信息

Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC, University of Seville, Seville, Spain.

Centre for Biomedical Network Research on Rare Diseases CIBERER, Seville, Spain.

出版信息

Orphanet J Rare Dis. 2021 Jan 6;16(1):4. doi: 10.1186/s13023-020-01665-5.

DOI:10.1186/s13023-020-01665-5
PMID:33407723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7789680/
Abstract

The relevant role of long non-coding RNAs (lncRNAs) in cancer is currently a matter of increasing interest. Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor (2-5% of all thyroid cancer) derived from the parafollicular C-cells which secrete calcitonin. About 75% of all medullary thyroid cancers are believed to be sporadic medullary thyroid cancer (sMTC), whereas the remaining 25% correspond to inherited cancer syndromes known as Multiple Endocrine Neoplasia type 2 (MEN2). MEN2 syndrome, with autosomal dominant inheritance is caused by germline gain of function mutations in RET proto-oncogene. To date no lncRNA has been associated to MEN2 syndrome and only two articles have been published relating long non-coding RNA (lncRNA) to MTC: the first one linked MALAT1 with sMTC and, in the other, our group determined some new lncRNAs in a small group of sMTC cases in fresh tissue (RMST, FTX, IPW, PRNCR1, ADAMTS9-AS2 and RMRP). The aim of the current study is to validate such novel lncRNAs previously described by our group by using a larger cohort of patients, in order to discern their potential role in the disease. Here we have tested three up-regulated (RMST, FTX, IPW) and one down-regulated (RMRP) lncRNAs in our samples (formalin fixed paraffin embedded tissues from twenty-one MEN2 and ten sMTC patients) by RT-qPCR analysis. The preliminary results reinforce the potential role of RMST, FTX, IPW and RMRP in the pathogenesis of MTC.

摘要

长链非编码RNA(lncRNAs)在癌症中的相关作用目前越来越受到关注。甲状腺髓样癌(MTC)是一种罕见的神经内分泌肿瘤(占所有甲状腺癌的2 - 5%),起源于分泌降钙素的滤泡旁C细胞。据信,所有甲状腺髓样癌中约75%为散发性甲状腺髓样癌(sMTC),其余25%对应于遗传性癌症综合征,即2型多发性内分泌腺瘤病(MEN2)。MEN2综合征为常染色体显性遗传,由RET原癌基因的种系功能获得性突变引起。迄今为止,尚无lncRNA与MEN2综合征相关联,仅有两篇文章发表了关于长链非编码RNA(lncRNA)与MTC的研究:第一篇将MALAT1与sMTC联系起来,另一篇中我们的研究小组在一小部分新鲜组织的sMTC病例中确定了一些新的lncRNAs(RMST、FTX、IPW、PRNCR1、ADAMTS9 - AS2和RMRP)。本研究的目的是通过使用更大的患者队列来验证我们小组先前描述的这些新型lncRNAs,以了解它们在该疾病中的潜在作用。在这里,我们通过RT - qPCR分析检测了我们样本(来自21例MEN2患者和10例sMTC患者的福尔马林固定石蜡包埋组织)中三个上调的lncRNAs(RMST、FTX、IPW)和一个下调的lncRNA(RMRP)。初步结果强化了RMST、FTX、IPW和RMRP在MTC发病机制中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a286/7789680/c8c676970e39/13023_2020_1665_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a286/7789680/c8c676970e39/13023_2020_1665_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a286/7789680/c8c676970e39/13023_2020_1665_Fig1_HTML.jpg

相似文献

1
RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer.RMRP、RMST、FTX和IPW:甲状腺髓样癌中新型潜在长链非编码RNA
Orphanet J Rare Dis. 2021 Jan 6;16(1):4. doi: 10.1186/s13023-020-01665-5.
2
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.在源自葡萄牙中部地区的2型多发性内分泌腺瘤病家族及散发性甲状腺髓样癌病例中,RET原癌基因出现Cys611Tyr突变及一种新型的Arg886Trp替代。
Clin Endocrinol (Oxf). 2006 Jun;64(6):659-66. doi: 10.1111/j.1365-2265.2006.02524.x.
3
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.甲状腺髓样癌 (MTC) 和 RET 原癌基因:家族性病例的突变谱和散发性病例研究的荟萃分析。
Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8.
4
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌患者RET原癌基因种系突变频率较低。
Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. doi: 10.1111/j.1365-2265.1995.tb01903.x.
5
RET oncogene mutations in medullary thyroid carcinoma in Mexican families.墨西哥家族性甲状腺髓样癌中的RET原癌基因突变
Arch Med Res. 2003 Jan-Feb;34(1):41-9. doi: 10.1016/s0188-4409(02)00461-7.
6
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.遗传性和散发性甲状腺髓样癌的基因诊断的临床实用性。
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.
7
Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.伊朗甲状腺髓样癌患者中RET原癌基因外显子10的突变谱倾斜
Tumour Biol. 2015 Jul;36(7):5225-31. doi: 10.1007/s13277-015-3179-7. Epub 2015 Feb 20.
8
RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.甲状腺髓样癌患者的RET基因筛查:摩洛哥的经验
J Cancer Res Ther. 2009 Jul-Sep;5(3):198-202. doi: 10.4103/0973-1482.57126.
9
Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.日本散发性甲状腺髓样癌患者中生殖系RET突变携带者:单中心经验
Auris Nasus Larynx. 2016 Oct;43(5):551-5. doi: 10.1016/j.anl.2015.12.016. Epub 2016 Feb 1.
10
A primer on the genetics of medullary thyroid cancer.《甲状腺髓样癌遗传学概论》。
Curr Oncol. 2019 Dec;26(6):389-394. doi: 10.3747/co.26.5553. Epub 2019 Dec 1.

引用本文的文献

1
LncRNAs in serum-derived extracellular vesicles are potential biomarker and correlated with immune infiltration in gastric cancer.血清来源的细胞外囊泡中的长链非编码RNA是潜在的生物标志物,与胃癌中的免疫浸润相关。
Front Immunol. 2025 Jan 24;16:1533111. doi: 10.3389/fimmu.2025.1533111. eCollection 2025.
2
Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer.单细胞转录组分析揭示去势抵抗性转移性前列腺癌中的长链非编码RNA图谱。
NPJ Genom Med. 2024 Feb 23;9(1):14. doi: 10.1038/s41525-024-00401-3.
3
m6A-Mediated Upregulation of Imprinted in Prader-Willi Syndrome Induces Aberrant Apical-Basal Polarization and Oxidative Damage in RPE Cells.

本文引用的文献

1
In Silico Analysis Identifies Differently Expressed lncRNAs as Novel Biomarkers for the Prognosis of Thyroid Cancer.基于计算机的分析鉴定出差异表达的 lncRNAs 作为甲状腺癌预后的新型生物标志物。
Comput Math Methods Med. 2020 Apr 23;2020:3651051. doi: 10.1155/2020/3651051. eCollection 2020.
2
LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p/EIF5A2 Axis.长链非编码RNA FTX通过调控miR-192-5p/EIF5A2轴促进结直肠癌进展。
Onco Targets Ther. 2020 Mar 31;13:2677-2688. doi: 10.2147/OTT.S241011. eCollection 2020.
3
LncRNAs as Potential Therapeutic Targets in Thyroid Cancer.
m6A介导的普拉德-威利综合征印记上调诱导视网膜色素上皮细胞异常的顶-基极化和氧化损伤。
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):10. doi: 10.1167/iovs.65.2.10.
4
Bioinformatics Analysis of the Inflammation-Associated lncRNA-mRNA Coexpression Network in Type 2 Diabetes.2 型糖尿病炎症相关 lncRNA-mRNA 共表达网络的生物信息学分析。
J Renin Angiotensin Aldosterone Syst. 2023 Feb 22;2023:6072438. doi: 10.1155/2023/6072438. eCollection 2023.
5
The long non-coding RNA rhabdomyosarcoma 2-associated transcript exerts anti-tumor effects on lung adenocarcinoma via ubiquitination of .长链非编码RNA横纹肌肉瘤2相关转录本通过……的泛素化对肺腺癌发挥抗肿瘤作用。 (原文此处不完整)
Ann Transl Med. 2022 Jan;10(1):10. doi: 10.21037/atm-21-6052.
6
Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancer.FTX表达上调与预后不良相关,并促进甲状腺癌的进展。
Oncol Lett. 2021 Sep;22(3):672. doi: 10.3892/ol.2021.12933. Epub 2021 Jul 18.
长链非编码RNA作为甲状腺癌潜在的治疗靶点
Asian Pac J Cancer Prev. 2020 Feb 1;21(2):281-287. doi: 10.31557/APJCP.2020.21.2.281.
4
LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1.长链非编码RNA FTX抑制通过调节miR-320a/TXNRD1抑制骨肉瘤增殖和迁移。
Cancer Biol Ther. 2020 Apr 2;21(4):379-387. doi: 10.1080/15384047.2019.1702405. Epub 2020 Jan 10.
5
Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.甲状腺癌发病的影响因素:分子遗传学基础。
Genes (Basel). 2019 Nov 8;10(11):913. doi: 10.3390/genes10110913.
6
RETRACTED: lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR.撤回:lncRNA RMST 通过与 HuR 相互作用增强 DNMT3 表达。
Mol Ther. 2020 Jan 8;28(1):9-18. doi: 10.1016/j.ymthe.2019.09.024. Epub 2019 Oct 4.
7
LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer.LncRNA LUCAT1 作为甲状腺乳头状癌患者的新型预后生物标志物。
Sci Rep. 2019 Oct 7;9(1):14374. doi: 10.1038/s41598-019-50913-7.
8
MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP.微小RNA-675直接靶向丝裂原活化蛋白激酶1以抑制甲状腺乳头状癌的致癌性,并被长链非编码RNA RMRP吸附。
Onco Targets Ther. 2019 Sep 6;12:7307-7321. doi: 10.2147/OTT.S213371. eCollection 2019.
9
Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.长链非编码 RNA 在间变性甲状腺癌中的表达。
Endocr Pathol. 2019 Dec;30(4):262-269. doi: 10.1007/s12022-019-09589-y.
10
'Metaphyseal dysplasia without hypotrichosis' can present with late-onset extraskeletal manifestations.“无脱发性干骺端发育不良”可表现为迟发性骨骼外表现。
J Med Genet. 2020 Jan;57(1):18-22. doi: 10.1136/jmedgenet-2019-106131. Epub 2019 Aug 14.